

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. Among its major competitors, Intercept Pharmaceuticals is ranked in 5th place for NPS while Seattle Genetics is 1st, and Biogen is 2nd.Their current market cap is $801.62M
Intercept Pharmaceuticals's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether Intercept Pharmaceuticals's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 0% | Passives |
| 100% | Detractors |
| Summary | Date | Score |
|---|---|---|
Jan 2021 -100 | Jan 2021 | -100 |
Aug 2022 -100 | Aug 2022 | -100 |
Aug 2025 -100 | Aug 2025 | -100 |
Intercept Pharmaceuticals is ranked #4 for NPS among its competitors. Seattle Genetics and Biogen come in first and second, with Novavax coming in at third. Among those competitors, it is the lowest valued company behind Biogen.
![]() Intercept Pharmaceuticals | ![]() Biogen | ![]() Seattle Genetics | ![]() Novavax | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | -100 | 21 | 40 | 0 |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | - | - |
| Valuation Updated every 24 hours for public companies | $801.62M | $42.46B | $26.00B | $13.39B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Intercept Pharmaceuticals's NPS is rated right below Reata Pharmaceuticals.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Seattle Genetics | 40 |
![]() | Biogen | 21 |
![]() | Esperion Therapeutics | 0 |
![]() | Novavax | 0 |
![]() | Aptalis Pharma | N/A |
![]() | MyoKardia | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | Intercept Pharmaceuticals | -100 |
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
10% of Intercept Pharmaceuticals users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, Intercept Pharmaceuticals's Customer Loyalty score is rated right above Aptalis Pharma, and is preceded by Seattle Genetics.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | MyoKardia | 100% |
![]() | Biogen | 75% |
![]() | Esperion Therapeutics | 69% |
![]() | Novavax | 55% |
![]() | Seattle Genetics | 48% |
![]() | Intercept Pharmaceuticals | 10% |
![]() | Aptalis Pharma | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
Intercept Pharmaceuticals has an overall Product Quality score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Intercept Pharmaceuticals' overall Product Quality score rated by its users and customers.
Intercept Pharmaceuticals’s product quality score is a 4 out of 5 as rated by its users and customers.
Compared to its competitors, Intercept Pharmaceuticals's Product Quality score is rated right above MyoKardia, and is preceded by Biogen.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Biogen | 4/5 |
![]() | Intercept Pharmaceuticals | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Seattle Genetics | 3.5/5 |
![]() | Novavax | 3.4/5 |
![]() | Esperion Therapeutics | 3.3/5 |
![]() | Aptalis Pharma | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
Intercept Pharmaceuticals has a value for money and ROI score of 2.5 out of 5 stars rated by its users and customers.
Sign Up to unlock Intercept Pharmaceuticals' overall ROI score rated by its users and customers.
Compared to its competitors, Intercept Pharmaceuticals's ROI score is rated right above Aptalis Pharma, and is preceded by Esperion Therapeutics.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | MyoKardia | 4/5 |
![]() | Seattle Genetics | 3.9/5 |
![]() | Biogen | 3.8/5 |
![]() | Novavax | 2.7/5 |
![]() | Esperion Therapeutics | 2.7/5 |
![]() | Intercept Pharmaceuticals | 2.5/5 |
![]() | Aptalis Pharma | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
Intercept Pharmaceuticals has an overall Customer Satisfaction score of 50 rated by its users and customers.
Sign Up to see the full customer demographics data and the people that answered "How would you rate your overall satisfaction with the service you received?"
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, Intercept Pharmaceuticals's Customer Satisfaction score is rated right above Seattle Genetics, and is preceded by Esperion Therapeutics.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | Novavax | 100% |
![]() | Biogen | 78% |
![]() | Esperion Therapeutics | 60% |
![]() | Intercept Pharmaceuticals | 50% |
![]() | Seattle Genetics | 28% |
![]() | Aptalis Pharma | 0% |
![]() | MyoKardia | 0% |
![]() | Portola Pharmaceuticals | 0% |
![]() | Reata Pharmaceuticals | 0% |
Intercept Pharmaceuticals has an overall Customer Service score of 2.5 out of 5 stars rated by its users and customers.
Sign Up to unlock Intercept Pharmaceuticals' overall Customer Service score rated by its users and customers.
18 Desbrosses Street, New York City, NY 10013
http://www.interceptpharma.com
646-747-1000
Compared to its competitors, Intercept Pharmaceuticals's Customer Service score is rated right above Aptalis Pharma, and is preceded by Esperion Therapeutics.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | Novavax | 4.2/5 |
![]() | MyoKardia | 4/5 |
![]() | Seattle Genetics | 3.8/5 |
![]() | Biogen | 3.8/5 |
![]() | Esperion Therapeutics | 3.1/5 |
![]() | Intercept Pharmaceuticals | 2.5/5 |
![]() | Aptalis Pharma | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
Intercept Pharmaceuticals scored a -100 for Net Promoter Score and a -25 for Employee Net Promoter Score. NPS gauges how likely a customer of Intercept Pharmaceuticals would recommend the brand to a friend. ENPS measures how likely Intercept Pharmaceuticals employees would recommend working at Intercept Pharmaceuticals to a friend.
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
| 25% | Promoters |
|---|---|
| 25% | Passive |
| 50% | Detractors |